In the News.. type 2 youth study, mini glucagon made easier, CGM via radio waves and more!
Diabetes Connections | Type 1 Diabetes
Release Date: 08/27/2021
The FDA pulled it, but the diabetes community wouldn’t let it go. How the T1D1 app made a comeback
Diabetes Connections | Type 1 Diabetes
Two years ago the FDA pulled down just about every insulin calculator app. A lot of them just disappeared, rather than seek official approval, but one of them – created by a teenager with type 1 – is back. I’m talking with Drew and Mike Mendelow about a free and ad-free insulin-dose calculator app. They share what it was like to navigate the FDA process, how they go international help, and what’s next. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to ...
info_outline
In the News... Universal T1D screening studied, Dexcom new product, Afrezza prescribing guidelines update, and more!
Diabetes Connections | Type 1 Diabetes
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: UK looks at starting universal T1D screening, Dexcom's CEO mentions a new product, bariatric sugery vs GLP medications, FDA approves update to prescribing info for inhaled insulin, miscroplastic and diabetes link studied, and more! Announcing Community Commericals! Learn how to Learn more about Please visit our Sponsors & Partners - they help make the show possible! from extreme temperatures The best way to keep up with Stacey and the show is...
info_outline
Chris Dunn got screened for her kids, turns out SHE has type 1 diabetes
Diabetes Connections | Type 1 Diabetes
Imagine getting your kids screened for T1D and agreeing to do it yourself, just to set a good example, and then your test is the one that comes back with type 1! That’s exactly what happened to Chris Dunn. She was positive for all of the autoantibodies and has since been treated with Tzield, the medication shown to delay the onset. We’re talking to her about all of that, what the treatment is actually like, how she’s doing since and what her family thinks of the whole thing. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health...
info_outline
In the News... New islets study, Tzield for babies, MiniMed Go approved, Civica insulin launched, and more!
Diabetes Connections | Type 1 Diabetes
It's In the News... the top diabetes stories and headlines happening now! Top stories this week include: new islet encapsulation trial, FDA agrees to review Tzield for babies and approves the MiniMed Go, Civica releases it's version of Lantus, Eversense launches with a pump partner, scholarship for college students with diabetes and more! Announcing Community Commericals! Learn how to Learn more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures The best way to keep up...
info_outline
GLP-1s for Type 1 Diabetes: Are We There Yet? With Dr. Cecilia Low Wang
Diabetes Connections | Type 1 Diabetes
One of the sure-thing top stories of 2026 will be GLP1s, but will we see more studies and even approval for treating type 1 with these medications? We're talking about Ozempic, Mounjaro and the next versions like Retatrutide - that are just around the corner. I’m talking to Dr. Cecelia Lo Wong, a diabetologist at the University of Colorado whose been on the front lines of this conversation for years, including serving on FDA advisory committees. This is a wide ranging interview - we also talk about the growing needs of older adults with type 1 diabetes, how kidney and...
info_outline
In the News PLUS our 2026 Predictions
Diabetes Connections | Type 1 Diabetes
It's In the News.. a look at the top headlines and stories in the diabetes community. This week we're also making predictions for diabetes news in 2026! This week's top stories: statins and type 2, big results from Lilly's newest weight loss drug, MiniMed IPO, Tandem app update, and more! Predicitons include thouhts around: continuous ketone monitoring, noninvasive gucose moniotring, inhalable insulin for kids, GLP1 backlash, A1 slop in diabetes mom groups and more! Announcing Community Commericals! Learn how to Learn more about Please visit our Sponsors & Partners -...
info_outline
Looking back on 2025: Hype, hope and what really matters, with Neil Greathouse
Diabetes Connections | Type 1 Diabetes
This week on Diabetes Connections, a conversation about what really matters in diabetes. We’re talking about the top stories of 2025, the hype that didn’t happen, some trends for 2026, what community can accomplish, and what LeBron James has to do with all of this. We also get personal – because I’m being interviewed by the wonderful Neil Greathouse, host of Your Best T1D life, and so much more. This episode contains a replay of This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community...
info_outline
Do We Need an At-Home A1C Test in the Age of CGM? Orange Biomed Says Yes
Diabetes Connections | Type 1 Diabetes
Making the case for a better at home A1C test. Orange Biomed is developing a compact, one-drop, at-home A1C testing device they say could make frequent A1C checks easier and more accessible than ever. They’re passionate about closing the gap for people who struggle to get to clinics regularly… and the research they share is compelling: four A1C tests a year can lead to a nearly 4% reduction in A1C levels. We’ll talk about why more frequent A1C monitoring matters—even in the era of continuous glucose monitoring—how their new device works, and what early clinical trial results look...
info_outline
She Turned Her Glucose Data Into Art. Could it Change How People See Diabetes?
Diabetes Connections | Type 1 Diabetes
What if your glucose graph became a tangible piece of art? Something you could pring out and put on your water bottle or the back of your laptop. I’ve seen this in person and it makes a big impact on people. This week I’m talking to Krista Shenaman about making this type of art, her journey with type 2 – and it’s been a journey, she took a “record breaking” 28 day walk after her diagnosis.. – why she thinks its helpful to look at data in a new way and more. Full disclosure: We recorded this interview way back in 2024! Technical issues and thought it was lost,...
info_outline
Dexcom’s 15-Day G7 Is Here: What’s Changing, What’s Next, and What You Need to Know
Diabetes Connections | Type 1 Diabetes
It’s been a big month for announcements from Dexcom! What does that mean for you? From the commercial launch of the 15 day sensor and a smart basal feature to the announced phase out of the G6 and more, I’m talking with Jessica Castle, vice president of Global Medical Affairs at Dexcom. We’re covering all of this news and she’s answering your questions. More about More about This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to Learn more about ...
info_outlineIt's "In the News..." the only LIVE diabetes newscast!
--
Top stories this week:
T2D screening guidelines to change
New Gvoke Kit approved
Gestational Diabetes cases up in younger women
Are magnets & radio waves coming to T1D care?
Update on #DiversityInDiabetes
--
Links and sources in the transcript
Check out Stacey's book: The World's Worst Diabetes Mom!
Join the Diabetes Connections Facebook Group!
Sign up for our newsletter here
-----
Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
-----
Get the App and listen to Diabetes Connections wherever you go!
Click here for iPhone Click here for Android
Episode Transcript below:
Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days. As always, I’m going to link up my sources in the Facebook comments – where we are live on Wednesday August 25th 2021 – and in the show notes at d-c dot com when this airs as a podcast.. so you can read more if you want, whenever you want.
XX
In the News is brought to you by Real Good Foods! Find them in your local grocery store, Target or Costco. Real Food You Feel Good About Eating.
XX
Top story this week.. the number of young people with type 2 nearly doubled in the United States from 2001 to 2017. These researchers found significant increases in all types of diabetes among both sexes and across racial and ethnic groups.
Type 1 diabetes remains more common among white youth. The highest rates of type 2 diabetes were seen in youth who are Black or Native American.
It's interesting that these CDC and NIH researchers say they don’t know the cause of the huge increase in type 2. They talk about rising obesity, but wonder what’s behind that? They also wonder if it’s because of increased screenings, environment or something else.
https://www.reuters.com/business/healthcare-pharmaceuticals/diabetes-surges-among-american-youth-study-shows-2021-08-24/
XX
Big change recommended in screening for adults with type 2. The U.S. Preventive Services Task Force now recommends screening for people who are overweight starting at age 35… five years earlier than recommended right now. That would include 40% of the US adult population. This task force recommends screenings that insurance companies must completely cover, without out of pocket costs to the insured, under the Affordable Care Act.
XX
FDA approval for Gvoke Kit to treat severe hypoglycemia. Xeris pharmaceuticals already provides Gvoke glucagon as an autoinjector and a prefilled syringe.. this Kit is for patients who prefer to draw up their own doses of glucagon using a vial and syringe. You don’t have to mix anything, it’s still a ready-to-use liquid glucagon.
Could be helpful to those who prefer mini-glucagon doses – which are NOT FDA approved – but are sometimes used during illness. Note that’s my comment, Xeris and the FDA is not talking about mini glucagon dosing at all.
https://www.fiercepharma.com/drug-delivery/xeris-a-rival-to-lilly-and-novo-gets-fda-nod-for-glucagon-kit
XX
Growing numbers of pregnant women are developing gestational diabetes. Between 2011 and 2019, rates of gestational diabetes in the United States jumped 30%, according to a large nationwide study of first-time mothers. The cause? Not clear. Every age group saw an increase – from 15 to 44 – so it’s not just moms getting older, which is happening. These researchers want to look at non -traditional risk factors like stress. This was a huge study – 13 million moms in the US.
https://www.upi.com/Health_News/2021/08/18/diabetes-pregnancy/7401629306285/
XX
In the – no thank you – department – researchers say they’ve got an implanted pump you’d refill just by swallowing a capsule. The catch? First, they have to implant the pump – which is described as the size of flip phone - along the abdominal wall, interfaced with the small intestine.
That refill capsule is magnetic, so the implant draws the capsule toward it. It then punches the capsule with a retractable needle and pumps the insulin into its reservoir. The needle must also punch through a thin layer of intestinal tissue to reach the capsule.
These Italian developers testing it all out in pigs – they say it controlled blood glucose successfully… for several hours.
https://spectrum.ieee.org/implantable-medical-devices
XX
Another maybe it’ll work item… Israeli startup Hagar has something called G-Wave technology that measures blood sugar levels using noninvasive radio waves.
The prototype puts the tech into a ceramic bracelet. Uses Bluetooth to transmit readings to an a mobile app with display and alert functions.
A proof-of-concept study found the company's radio frequency technology was able to continuously measure glucose levels with at least 90% accuracy, compared to the estimated 70% rate for traditional continuous glucose monitors. They claim that’s because it measures glucose in real time. Hagar now plans to launch clinical trials to pursue FDA approval
XX
More to come, but first, I want to tell you about one of our great sponsors who helps make Diabetes Connections possible.
Real Good Foods. Where the mission is Be Real Good
They make nutritious foods— grain free, high in protein, never added sugar and from real ingredients— I was in Target this week and I saw the new Entrée bowls, I bought the Lemon Chicken and the Lasagna. The Lemon chicken was great! It uses hearts of palm pasta instead of regular noodles which I thought sounded odd but really tasted good. They keep adding to the menu line! You can buy online or find a store near you with their locator right on the website. I’ll put a link in the FB comments and as always at d-c dot com.
Back to the news…
XX
Big grant goes to Scripps Whittier Diabetes Institute to study the use of CGMs in hospitalized patients with type 2. This is a $3.1 million dollar grant from The National Institutes of Health. It’s to build on research going on now – during the COVID-19 pandemic.
CGM devices have been approved for outpatient use since 1999, but their use in the hospital setting remains limited to research efforts and the special conditions allowed during the pandemic.
XX
Congrats to Diversity in Diabetes for their newly minted 501c3 status.
The group was founded last summer and is dedicated to creating awareness and providing solutions to end health disparities and the lack of representation in the diabetes space. Their big event – People of Color Living with Diabetes Virtual Summit kicks off Sept 16 – more info and how to register in the show notes.
XX
Please join me wherever you get podcasts for our next episode -Tuesday – we’re talking to the folks from MannKind, makers of Afrezza inhalable insulin. You had a lot of questions for them.. looking forward to that episode! The episode out right now is with Kyle Banks – a Broadway performer diagnosed with type 1 while acting in the Lion King.
That’s In the News for this week.. if you like it, please share it! If you’re watching this replay on YouTube please subscribe, if you’re listening via the audio podcast please follow. Whatever it’s called – I appreciate you being here. Thanks for joining me!